Earnings Preview For Zillow Group
Zillow Group (NASDAQ:Z) is set to give its latest quarterly earnings report on Tuesday, 2021-11-02. Here's what investors need to know before the announcement.
Analysts estimate that Zillow Group will likely report an Earnings Per Share (EPS) of $0.14
Zillow Shares Quiet Following Business Insider Article ‘Zillow is selling hundreds of homes in places like Atlanta, Phoenix, and Houston. An Insider analysis found almost two-thirds are listed for less than it paid’
https://www.businessinsider.com/zillow-offers-pause-ibuyers-homes-atlanta-phoenix-dallas-houston-minneapolis-2021-10
46 Biggest Movers From Yesterday
Gainers
Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.
PreMarket Prep Stock Of The Day: Zillow Group
When a stock is in a downtrend and the company comes out with bad news, on most occasions the issue declines in price in the short term. Whether or not longer-term investors use the weakness in price to accumulate shares of the issue, regardless of the recent news, is the question.
34 Stocks Moving In Monday’s Mid-Day Session
Gainers
Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.
Why Zillow Homebuying Halt ‘Might Be Beneficial’ In The Near-Term
Online real estate listing platform Zillow Group Inc (NASDAQ: Z) is reportedly pausing its iBuying program through at least the end of 2021 after the company purchased more than 3,800 homes in the second quarter.
Why Zillow Shares Are Tumbling Today
Zillow Group Inc (NASDAQ: Z) (NASDAQ: ZG) is trading lower Monday morning after the company put its home purchasing program on pause to work through the renovation and selling of homes it has already purchased.
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.